In vitro affinity maturation of human GM-CSF antibodies by targeted CDR-diversification

抗体 亲和力成熟 细胞因子 生物 受体 体外 体细胞突变 免疫系统 免疫学 分子生物学 细胞生物学 B细胞 生物化学
作者
Stefan Steidl,Olaf Ratsch,Bodo Brocks,Manuela Dürr,Elisabeth Thomassen-Wolf
出处
期刊:Molecular Immunology [Elsevier]
卷期号:46 (1): 135-144 被引量:85
标识
DOI:10.1016/j.molimm.2008.07.013
摘要

The mammalian immune system applies somatic hypermutation to select for antibodies with improved dissociation rates in vivo up to an intrinsic limit, previously termed as affinity ceiling. However, for certain therapeutic applications it may be desirable to further improve antibody affinities beyond that limit. In this study the selection of antibodies specific for the pro-inflammatory cytokine granulocyte-macrophage colony-stimulating factor (GM-CSF) from the HuCAL GOLD human antibody library is described. In order to increase affinity and also functional activity, in vitro affinity maturation of a pool of lead Fab candidates was carried out. CDR-L3 and parallel CDR-H2 diversification using trinucleotide consensus cassettes were followed by the combination of optimized CDR-L3 and CDR-H2 leading to a 5000-fold improved affinity finally reaching a KD of 400 fM. Cytokine neutralizing potential of MOR04357 was evaluated in a TF-1 proliferation assay. Along with affinity optimization a 2000-fold increase in potency was observed compared to the parental antibody. Due to species cross-reactivity MOR04357 also blocks rat GM-CSF induced proliferation of FDCP-1 cells. Receptor inhibition studies showed that MOR04357 prevents the interaction of GM-CSF with the GM-CSF receptor alpha chain. As a consequence this leads to a blockade in signal transduction as measured by abolished STAT5 phosphorylation in the presence of GM-CSF and antibody. Due to its pro-inflammatory role GM-CSF has been implicated in the pathophysiology of inflammatory diseases like rheumatoid arthritis or asthma. Based on the mode of action described herein MOR04357 shows favourable antibody features as a potential drug candidate.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
daydayup完成签到 ,获得积分10
1秒前
aaaaaa完成签到,获得积分10
4秒前
Jieh完成签到,获得积分10
4秒前
DAHove完成签到 ,获得积分10
6秒前
LEOhard完成签到,获得积分10
8秒前
YifanWang应助一个小胖子采纳,获得10
9秒前
不吃芹菜完成签到,获得积分10
9秒前
丘比特应助杨杨杨采纳,获得10
10秒前
blue完成签到 ,获得积分10
12秒前
pwang_ecust完成签到,获得积分10
13秒前
科研通AI2S应助活力的赛君采纳,获得10
14秒前
Hua完成签到,获得积分0
14秒前
pufanlg完成签到,获得积分10
16秒前
千瓦时醒醒完成签到,获得积分10
16秒前
小黄不慌完成签到,获得积分10
18秒前
传奇3应助背后半烟采纳,获得10
18秒前
wwxd完成签到,获得积分10
20秒前
xhsz1111完成签到 ,获得积分10
21秒前
21秒前
Liziqi823完成签到,获得积分10
22秒前
fsy123发布了新的文献求助10
24秒前
25秒前
外向的斑马完成签到 ,获得积分10
26秒前
大个应助fsy123采纳,获得10
29秒前
沉默采波完成签到 ,获得积分10
36秒前
Hou完成签到 ,获得积分10
36秒前
YifanWang应助一个小胖子采纳,获得10
39秒前
WonderC完成签到 ,获得积分10
41秒前
realtimes完成签到,获得积分10
43秒前
健壮的半青完成签到 ,获得积分10
45秒前
刘晓伟完成签到,获得积分10
45秒前
gan完成签到,获得积分10
46秒前
眯眯眼的青文完成签到,获得积分10
46秒前
Raul完成签到 ,获得积分10
46秒前
大气建辉完成签到 ,获得积分10
46秒前
隐形飞雪完成签到,获得积分10
47秒前
外向的凝阳完成签到 ,获得积分10
48秒前
社恐Forza完成签到 ,获得积分10
48秒前
轩辕书白完成签到,获得积分10
49秒前
高分求助中
Spray / Wall-interaction Modelling by Dimensionless Data Analysis 2000
Write Like a Chemist: A Guide and Resource (第二版) 600
Mixed-anion Compounds 600
A new species of Velataspis (Hemiptera Coccoidea Diaspididae) from tea in Assam 500
Earth System Geophysics 500
Aspects of Babylonian celestial divination: the lunar eclipse tablets of Enūma Anu Enlil 500
Geochemistry, 2nd Edition 地球化学经典教科书第二版 401
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3200827
求助须知:如何正确求助?哪些是违规求助? 2850571
关于积分的说明 8072502
捐赠科研通 2514324
什么是DOI,文献DOI怎么找? 1347061
科研通“疑难数据库(出版商)”最低求助积分说明 640332
邀请新用户注册赠送积分活动 610520